Clinical Trials Insight: 700028493
Phase of Trial: Phase I
Latest Information Update: 07 May 2008
At a glance
- Drugs TC 6499 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- Sponsors Targacept
- 07 May 2008 Status changed from initiated to completed, according to a Targacept media release.
- 15 Nov 2007 New trial record.
- 09 Nov 2007 Dosing is expected to commence in the next few weeks.